USANA built its business over three decades on a simple machine: recruit independent distributors, sell them vitamins, watch them recruit more. At its peak around 2020, that machine hummed loud enough to push annual revenue past a billion dollars. Then it started losing customers, quarter after quiet quarter, and the stock followed. Today the shares trade near a fraction of where they were a year ago. The question the latest filing forces is whether the customer bleed is slowing, or whether it’s become the new normal.
In one breath
The 10-Q for the quarter ended July 4, 2026 shows a company that generated real cash while reporting a headline loss, because a single accounting charge distorted the bottom line. Strip that charge away and the core nutritional business is shrinking slowly, not collapsing. The stock is priced at less than a third of its decade-median revenue multiple, which means the market is treating the shrinkage as permanent. Whether it is depends almost entirely on one number: active customers, which fell again.
A loss that isn’t quite what it looks like
USANA reported a net loss of $21.4 million for Q2 2026, a figure that looks alarming until you find the footnote. A $29.1 million non-cash goodwill impairment charge on the Hiya reporting unit drove the result. Goodwill impairment, in plain terms, is an accounting admission that an acquisition is worth less than what was paid for it. USANA acquired a controlling stake in Hiya, a children’s vitamin subscription brand, in December 2024. By August 2026, the math on that deal had soured enough to require a write-down. The cash never left the building; the loss is a pencil mark, not a payment.
Set that charge aside and the operating picture is sobering but not catastrophic. The company generated meaningful free cash flow during the quarter, and the August 4 earnings release confirmed $169 million in cash on the balance sheet with zero debt. A business sitting on that kind of cushion, with no creditors to satisfy, has time to work with. Whether management uses that time well is a different question.
The number that actually matters
Revenue fell from $236 million in Q2 2025 to $223 million in Q2 2026, a drop of about 6%. That decline has a specific cause: fewer customers. Active Core Nutritional customers fell to 384,000 from 418,000 a year earlier, roughly one in twelve regular buyers stopped buying over the course of a year.
Here is the detail worth holding onto. Revenue per remaining customer actually rose slightly, according to our data computed from filed figures. The people who stayed spent a little more. The problem is that the base keeps shrinking, and a higher average ticket on a smaller crowd is a treadmill, not a recovery.
The 10-K for fiscal year ended January 3, 2026 shows this pattern is not new. Annual revenue peaked above a billion dollars in 2020 and has declined in most years since. The core nutritional segment still carries the company. Everything else is a rounding error or a bet on the future.
The Hiya problem, stated plainly
USANA’s venture into Hiya was a deliberate pivot: direct-to-consumer subscriptions, a younger demographic, a brand that lives on Instagram rather than in distributor meetings. The theory was sound. The execution has been painful. Active monthly subscribers fell by roughly a sixth compared to a year earlier. CEO Kevin Guest, on the August 11 earnings call, attributed the decline to a “tougher and more expensive digital marketing environment” and “Meta algorithm shifts affecting subscriber acquisition.” In plain terms: the ads stopped working as well, and acquiring new subscribers got more expensive just as the old ones were leaving.
The impairment charge is the accounting consequence of that story. It does not mean Hiya is worthless, but it does mean the original price tag was too high.
What the balance sheet says about the inventory
One quiet positive in the Q2 2026 10-Q balance sheet: inventory fell meaningfully from the start of the fiscal year to July, dropping from roughly $103 million to $86 million. A company selling fewer products that also holds less inventory is at least managing the mismatch between supply and demand. The alternative, a warehouse filling up while sales fall, would signal a much deeper problem. This one does not.
What the market is paying versus what the filings show
The math and the mood, as we use those terms at BullScope, are unusually far apart here. The math is what filed fundamentals justify; the mood is what the market is currently paying. Our data shows the stock trading at roughly a quarter of what it has historically fetched per dollar of USANA revenue. Zacks Equity Research, as reported by Morningstar on August 4, carries a “Strong Sell” rating, with analyst earnings estimates for the current quarter having collapsed from more than 40 cents per share to barely above a dime. That is a dramatic revision, and it explains some of the mood.
The gap between a rock-bottom revenue multiple and a deteriorating earnings estimate is not necessarily an opportunity. It can also be a warning that the market has correctly identified a business in structural decline. The filed numbers cannot resolve that question. What they can say is that the company has the cash to keep testing its answer.
Reading the numbers
- $223 million in Q2 2026 net sales (10-Q, July 4, 2026): total revenue for the quarter. It means the business brought in about $2.4 million per day. Down from $236 million a year earlier, so roughly $140,000 less per day than twelve months ago.
- 384,000 active Core Nutritional customers (Direct Selling News, August 5, 2026): the count of people who bought at least once in the quarter. Down from 418,000. Imagine a stadium that holds 418,000 fans: 34,000 seats are now empty compared to last year.
- $21.4 million net loss vs. $20 million free cash flow (10-Q, July 4, 2026): the loss is accounting; the cash is real. A household that writes down the value of a car it overpaid for shows a loss on paper but still has money in the bank. Same idea here.
- $29.1 million Hiya impairment (earnings release, August 4, 2026): a non-cash charge admitting the Hiya acquisition is worth less than its purchase price. No cash leaves the company; the write-down simply corrects the balance sheet to reflect reality.
- $169 million cash, zero debt (Morningstar, citing earnings release, August 4, 2026): the company holds cash equal to more than seven months of revenue with no loans outstanding. That is a meaningful buffer for a business in transition.
- P/S ratio of 0.3 vs. decade median of 1.1 (our data, computed from SEC filings and market prices): the price-to-sales ratio is the price tag per dollar of annual revenue. At 0.3, the market pays 30 cents for each dollar USANA earns in sales. Historically it has paid $1.10. That gap is either a bargain or a verdict.
Sources
- USANA 10-Q, quarter ended July 4, 2026 (SEC EDGAR)
- USANA 10-K, fiscal year ended January 3, 2026 (SEC EDGAR)
- USANA 10-K, fiscal year ended December 28, 2024 (SEC EDGAR)
- USANA Q2 2026 10-Q balance sheet detail (IR site)
- USANA Q2 2026 earnings release (Signal News Nashville, August 4, 2026)
- Morningstar, citing BusinessWire earnings release, August 4, 2026
- USANA Q2 2026 earnings call transcript (Motley Fool, August 11, 2026)
- Direct Selling News, USANA Q2 2026 results, August 5, 2026
